BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 33468140)

  • 1. Circular RNA circSDHC serves as a sponge for miR-127-3p to promote the proliferation and metastasis of renal cell carcinoma via the CDKN3/E2F1 axis.
    Cen J; Liang Y; Huang Y; Pan Y; Shu G; Zheng Z; Liao X; Zhou M; Chen D; Fang Y; Chen W; Luo J; Zhang J
    Mol Cancer; 2021 Jan; 20(1):19. PubMed ID: 33468140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circular RNA circSDHC (hsa_circ_0015004) regulates tumor growth and angiogenesis via regulating centrosomal protein 55 expression in renal cell carcinoma.
    Pei L; Dong C; Wang Y; Lv X; Jia G; Zhang A
    Histol Histopathol; 2022 Oct; 37(10):971-983. PubMed ID: 35506422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circular RNA hsa_circ_0054537 sponges miR-130a-3p to promote the progression of renal cell carcinoma through regulating cMet pathway.
    Li R; Luo S; Zhang D
    Gene; 2020 Sep; 754():144811. PubMed ID: 32464246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circular RNA EGLN3 silencing represses renal cell carcinoma progression through the miR-1224-3p/HMGXB3 axis.
    Zhang G; Wang J; Tan W; Han X; Han B; Wang H; Xia Y; Sun Y; Li H
    Acta Histochem; 2021 Sep; 123(6):151752. PubMed ID: 34274607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circ_0000274 contributes to renal cell carcinoma progression by regulating miR-338-3p/NUCB2 axis and JAK1/STAT3 pathway.
    Qi Q; Sun Y; Yang Y; Liu Y
    Transpl Immunol; 2022 Oct; 74():101626. PubMed ID: 35569717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CircRNA cRAPGEF5 inhibits the growth and metastasis of renal cell carcinoma via the miR-27a-3p/TXNIP pathway.
    Chen Q; Liu T; Bao Y; Zhao T; Wang J; Wang H; Wang A; Gan X; Wu Z; Wang L
    Cancer Lett; 2020 Jan; 469():68-77. PubMed ID: 31629934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circular RNA circCSNK1G3 induces HOXA10 signaling and promotes the growth and metastasis of lung adenocarcinoma cells through hsa-miR-143-3p sponging.
    Lu T; Qiu T; Han B; Wang Y; Sun X; Qin Y; Liu A; Ge N; Jiao W
    Cell Oncol (Dordr); 2021 Apr; 44(2):297-310. PubMed ID: 33118120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. circAMOTL1L Suppresses Renal Cell Carcinoma Growth by Modulating the miR-92a-2-5p/KLLN Pathway.
    Gao L; Shao X; Yue Q; Wu W; Yang X; He X; Li L; Hou F; Zhang R
    Oxid Med Cell Longev; 2021; 2021():9970272. PubMed ID: 34646428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CircNTNG1 inhibits renal cell carcinoma progression via HOXA5-mediated epigenetic silencing of Slug.
    Liang Y; Cen J; Huang Y; Fang Y; Wang Y; Shu G; Pan Y; Huang K; Dong J; Zhou M; Xu Y; Luo J; Liu M; Zhang J
    Mol Cancer; 2022 Dec; 21(1):224. PubMed ID: 36536414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. circPTCH1 promotes invasion and metastasis in renal cell carcinoma via regulating miR-485-5p/MMP14 axis.
    Liu H; Hu G; Wang Z; Liu Q; Zhang J; Chen Y; Huang Y; Xue W; Xu Y; Zhai W
    Theranostics; 2020; 10(23):10791-10807. PubMed ID: 32929380
    [No Abstract]   [Full Text] [Related]  

  • 11. A novel circRNA, circNUP98, a potential biomarker, acted as an oncogene via the miR-567/ PRDX3 axis in renal cell carcinoma.
    Yu R; Yao J; Ren Y
    J Cell Mol Med; 2020 Sep; 24(17):10177-10188. PubMed ID: 32729669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CircTLK1 promotes the proliferation and metastasis of renal cell carcinoma by sponging miR-136-5p.
    Li J; Huang C; Zou Y; Ye J; Yu J; Gui Y
    Mol Cancer; 2020 Jun; 19(1):103. PubMed ID: 32503552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circular RNA MYLK promotes tumour growth and metastasis via modulating miR-513a-5p/VEGFC signalling in renal cell carcinoma.
    Li J; Huang C; Zou Y; Yu J; Gui Y
    J Cell Mol Med; 2020 Jun; 24(12):6609-6621. PubMed ID: 32342645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The circRNA circSEPT9 mediated by E2F1 and EIF4A3 facilitates the carcinogenesis and development of triple-negative breast cancer.
    Zheng X; Huang M; Xing L; Yang R; Wang X; Jiang R; Zhang L; Chen J
    Mol Cancer; 2020 Apr; 19(1):73. PubMed ID: 32264877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The E2F1-miR-520/372/373-SPOP Axis Modulates Progression of Renal Carcinoma.
    Ding M; Lu X; Wang C; Zhao Q; Ge J; Xia Q; Wang J; Zen K; Zhang CY; Zhang C
    Cancer Res; 2018 Dec; 78(24):6771-6784. PubMed ID: 30348808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CircSCNN1A inhibits the proliferation, migration and invasion of renal cell carcinoma cells by decreasing CLDN8 expression through miR-590-5p.
    Guo T; Xiong W; Liu C; Zhu L; Xie L
    Genesis; 2024 Jun; 62(3):e23599. PubMed ID: 38764323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-Regulation of Circular RNA_000926 Attenuates Renal Cell Carcinoma Progression through miRNA-411-Dependent CDH2 Inhibition.
    Zhang D; Yang XJ; Luo QD; Fu DL; Li ZL; Zhang P; Chong T
    Am J Pathol; 2019 Dec; 189(12):2469-2486. PubMed ID: 31476285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. circRNA hsa_circ_104566 Sponged miR-338-3p to Promote Hepatocellular Carcinoma Progression.
    Liu G; Guo W; Rao M; Qin J; Hu F; Li K
    Cell Transplant; 2020; 29():963689720963948. PubMed ID: 33028110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-suppressive effects of microRNA-181d-5p on non-small-cell lung cancer through the CDKN3-mediated Akt signaling pathway in vivo and in vitro.
    Gao LM; Zheng Y; Wang P; Zheng L; Zhang WL; Di Y; Chen LL; Yin XB; Tian Q; Shi SS; Xu SF
    Am J Physiol Lung Cell Mol Physiol; 2019 May; 316(5):L918-L933. PubMed ID: 30628487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor promoting effects of circRNA_001287 on renal cell carcinoma through miR-144-targeted CEP55.
    Feng J; Guo Y; Li Y; Zeng J; Wang Y; Yang Y; Xie G; Feng Q
    J Exp Clin Cancer Res; 2020 Dec; 39(1):269. PubMed ID: 33256799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.